Taysha Gene Therapies

On a mission to eradicate monogenic CNS disease.

Launch date

Jan 2020

Employees

Market cap

Net debt

-

Enterprise valuation

$398m (Public information from May 2024)

Dallas Texas (HQ)

https://tayshagtx.com/

https://twitter.com/tayshagtx https://www.linkedin.com/company/taysha-gene-therapies

View job openings

Authorizing premium user...